Article info

Download PDFPDF
Sporadic adenomatous polyp regression with exisulind is effective but toxic: a randomised, double blind, placebo controlled, dose-response study
  1. Correspondence to:
    Professor N Arber
    Integrated Comprehensive Cancer Prevention Center, Tel-Aviv Sourasky Medical Center, Tel-Aviv 64239, Israel; nadir{at}tasmc.health.gov.il or narber{at}post.tau.ac.il
View Full Text

Citation

Arber N, Kuwada S, Leshno M, et al
Sporadic adenomatous polyp regression with exisulind is effective but toxic: a randomised, double blind, placebo controlled, dose-response study

Publication history

  • Accepted August 30, 2005
  • Revised August 22, 2005
  • First published September 8, 2005.
Online issue publication 
February 10, 2006

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.